Company intelligence / Profile preview
SaponiQx
Lexington, Massachusetts, United Statessaponiqx.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SaponiQx has commercialized the proprietary saponin-based adjuvant STIMULON™ QS‑21, which forms a key component of the AS01 adjuvant used in several leading vaccines such as GSK’s Shingrix. The company’s cell culture–based manufacturing process enables scalable and sustainable production compared to traditional extraction from Chilean tree bark. Clinical results for products using their technology include high efficacy rates in approved vaccines like Shingrix. Next-generation programs are at discovery or preclinical stages.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Vaccine adjuvant (Saponin-based)Biologic (adjuvants are biologically derived)Small molecule (saponins are small molecules by structure)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Ginkgo Bioworks – strategic partnership on cell programming and metabolic engineering for novel/adaptive manufacturing processes and new vaccine/adjutant discoveryProbius – collaboration on quantum molecular spectroscopy–driven AI design of new saponinsU.S. Department of Defense DTRA funding support.
Beyond the preview
Go deeper on SaponiQx.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SaponiQx.